$692,422
＋5.1%
Chief Executive Officer
2024
$652k org
40 hrs/wk
$42k other
--
Chief Executive Officer at Alzheimer's Drug Discovery Foundation
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Mark Roithmayr has been listed as an employee of Alzheimer's Drug Discovery Foundation in Form 990 filings since fiscal year 2017. Total compensation for Mark Roithmayr has increased by 8% from 2017 to 2024.